Basic Periactin Information

• INN (International Nonproprietary Name): Cyproheptadine
• Brand Names Available In Canada (English): Not specified
• ATC Code: R06AX02
• Forms & Dosages: Tablet 4 mg; Syrup 2 mg/5 mL
• Manufacturers In Canada (English): Not specified
• Registration Status In Canada (English): Not specified
• OTC / Rx Classification: Not specified

Instructions, Warnings And Daily-Life Integration

Are you wondering how to use Periactin or cyproheptadine safely at home?

Read the product label and check for a valid Health Canada Drug Identification Number (DIN) before use, or ask a pharmacist if Periactin or cyproheptadine is registered or imported into your province.

If uncertain, consult the Health Canada Drug Product Database and talk to your pharmacist for confirmation.

Common product strengths include cyproheptadine tablets 4 mg and syrup 2 mg per 5 mL, so verify strength on the label.

Avoid cyproheptadine if allergic to cyproheptadine or if taking monoamine oxidase inhibitors (MAOIs) currently or within the last 14 days.

Use caution in elderly patients and anyone with liver or kidney impairment, prostate enlargement, pregnancy, or breastfeeding.

Seek urgent care for overdose signs such as agitation, severe drowsiness, or marked anticholinergic effects.

Plan dosing around work or school because sedation is common; carry a medication card listing cyproheptadine.

Keep medication in original packaging and store below 25°C.

Printable checklist for safety actions at home:

• Verify DIN or ask your pharmacist.
• Check for allergies and MAOI use.
• Store below 25°C in original box.
• Carry a medication card with drug name and dose.
• Seek urgent care for overdose signs.

Short printable emergency card for patients: Drug name, dose, emergency contact, and “avoid MAOIs within 14 days.”

Everyday Use & Best Practices

How should Periactin / cyproheptadine be split into morning and evening doses?

For most adults the standard regimen is one 4 mg tablet up to three times daily.

Many Canadians take the larger dose in the evening to reduce daytime sedation and impairment at work or school.

When used to stimulate appetite, spacing doses mid-morning and early evening may boost mealtime appetite while limiting drowsiness during commutes.

Cyproheptadine can be taken with or without food, although a small snack may reduce transient nausea.

High-fat meals common in some regional diets do not cause clinically important interactions but gastric tolerance can vary between individuals.

Dosing tips:

• Start with the lowest effective dose and move up only if needed.
• Take the largest dose in the evening if sedation is troublesome.
• Keep a dose log to track sleepiness and appetite effects.
• Ask a pharmacist about Periactin tablets vs generic cyproheptadine tablets if product authenticity is a concern.
• Do not combine with alcohol or other sedatives when starting therapy.

Morning Vs Evening Dosing In Canadian Routines

Many people prefer evening-heavy dosing to limit daytime sedation and preserve alertness for work and school.

For appetite stimulation, splitting doses mid-morning and early evening can increase mealtime hunger while lowering the risk of drowsiness during commutes.

Shift workers and people with irregular schedules should coordinate doses with their main sleep period and consult occupational health if safety-sensitive work is involved.

Taking With Or Without Meals (Canadian Diet Context)

Cyproheptadine may be taken with or without food and taking it with a light snack can ease transient nausea.

No clinically important interactions with high-fat meals have been reported, but tolerance varies by person.

Patients on multiple medications or with gastrointestinal conditions should consult a pharmacist about timing with meals and other drugs.

Safety Priorities

Who should avoid Periactin or cyproheptadine entirely?

Absolute contraindications include known hypersensitivity to cyproheptadine, newborns and premature infants, acute asthmatic attacks, angle-closure glaucoma, bladder neck obstruction, and concurrent or recent (within 14 days) MAOI use.

In Canada always check the Health Canada Drug Product Database and consult your prescriber if pregnant or breastfeeding.

Use caution in elderly patients, and those with liver or renal impairment, prostatic hypertrophy, or seizure history.

Cyproheptadine frequently causes drowsiness and impaired alertness, so limit activities that require full attention until the drug’s effects are known.

Do not drive, operate heavy machinery, or perform safety-sensitive tasks until you confirm your tolerance to the drug.

Shift workers and commercial drivers should document effects with employer or occupational health before resuming safety-critical duties.

“Do Not Do” checklist:

• Do not mix with MAOIs or start within 14 days of stopping an MAOI.
• Do not drive or use heavy machinery until you know how it affects you.
• Do not use in newborns or infants under 2 years.
• Do not exceed recommended doses or double up after a missed dose.

Printable pharmacist counselling points: check MAOI history, review other sedatives, advise storage under 25°C, and explain overdose signs.

Dosage & Adjustments

What are common starting doses and how should they be adjusted?

The typical adult dose for allergic symptoms is 4 mg (one tablet) three times daily.

Pediatric starters are often 2 mg (half a 4 mg tablet) two to three times daily for children aged two years and older.

Some formulations such as syrup are 2 mg per 5 mL and may be used for dose titration in children.

Verify the product’s DIN or any import authorisation in Canada because availability and prescription status vary by province.

Start low and slow in elderly patients because central nervous system effects are more likely and more severe.

For patients with hepatic or renal impairment consider a reduced initial dose and monitor closely for sedation or anticholinergic effects.

Avoid use in infants under two years.

Checklist for dose adjustments in liver/renal disease: start lower, monitor sedation, review concomitant meds, and schedule follow-up after 2–6 weeks.

User Testimonials

What do Canadian patients say about Periactin and cyproheptadine?

Many Canadians report improved appetite and measurable weight gain when prescribed cyproheptadine off-label for appetite stimulation.

Some patients describe relief from allergic itching when second‑generation antihistamines failed.

Positive accounts often note evening dosing to avoid daytime sedation and consulting pharmacists to confirm product authenticity, especially with imported brands.

Common challenges reported on Canadian forums and Reddit threads include daytime drowsiness, dry mouth, difficulty concentrating, and confusion in older adults.

Online threads stress checking for legitimate DINs and comparing prices between Shoppers Drug Mart, Rexall, and online pharmacies.

Users warn against buying foreign-labelled tablets without a pharmacist review.

• Pros: Appetite gain, itch relief when other antihistamines fail, inexpensive generics available abroad.
• Cons: Sedation, anticholinergic side effects, variable regulatory status in Canada.

Quoted vignette (anonymized): “Evening dose helped my appetite without making me sleepy at work once we shifted timing with the pharmacist’s advice.”

Buying Guide

Where can Canadians get Periactin or cyproheptadine and what should be checked before purchase?

Availability in Canada varies by province and product; national chains such as Shoppers Drug Mart, Rexall, Jean Coutu (Quebec), and London Drugs can often order Periactin or suggest equivalent alternatives.

Ask your pharmacist whether the branded Periactin or generic cyproheptadine has a valid DIN or is being supplied via an import notice.

Prices vary by format (4 mg tablets, syrup 2 mg/5 mL) and by brand.

Online retailers may list Periactin or international generics but confirm regulatory status and avoid unknown vendors without pharmacist verification.

Cross‑border purchases from the United States may provide access to generics but customs rules and provincial drug plan coverage differ.

Provincial plans such as Ontario Drug Benefit, BC PharmaCare, and RAMQ may not cover import costs; check each formulary for coverage rules.

In our online pharmacy, periactin is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Safe online-purchase checklist: confirm DIN, read reviews of the vendor, ask the pharmacist to verify foreign labelling, and keep receipts for customs or insurance claims.

What’s Inside & How It Works

What are the active ingredient and common excipients to watch for?

The active ingredient is cyproheptadine hydrochloride, INN: cyproheptadine.

Common tablet strength is 4 mg and syrup is typically 2 mg per 5 mL.

Excipients vary by manufacturer and may include lactose or dyes, so check labels for allergens and bilingual labelling in Canada.

Cyproheptadine belongs to first‑generation antihistamines (ATC R06AX02) and has anticholinergic and serotonin-blocking actions.

These non‑selective effects explain both its therapeutic benefits for allergy relief and appetite stimulation and its common sedative and anticholinergic side effects.

Mechanism-related side effects include drowsiness, dry mouth, urinary retention, and possible visual disturbances due to anticholinergic action.

Main Indications

What is Periactin officially used for and how do Canadian prescribers use it off-label?

Internationally, cyproheptadine is used for allergic reactions and pruritus, and standard allergy dosing is 4 mg three times daily.

In Canada, prescribers may use cyproheptadine for severe allergic symptoms when alternatives are ineffective, but patients should check Health Canada for current approved indications and DIN status.

Common off‑label uses by Canadian physicians include appetite stimulation for cachexia or pediatric failure to thrive and migraine prophylaxis in select cases.

Off‑label prescribing should be clinician‑led with informed consent and monitoring because of sedative and anticholinergic risks.

Monitoring checklist for off‑label therapy: track weight and appetite, document baseline vitals, review other meds, and reassess after 2–6 weeks.

Interaction Warnings

What foods, substances, and drugs increase risks when combined with cyproheptadine?

Alcohol potentiates sedation and impairment and should be avoided when starting therapy.

Caffeine will not reliably reverse anticholinergic sedation.

Cannabis and high‑alcohol meals commonly used in Canada can exaggerate drowsiness and cognitive effects.

Avoid concurrent MAOI use and do not start cyproheptadine within 14 days of stopping an MAOI.

Be cautious with other sedatives such as benzodiazepines and opioids, and with medications that have anticholinergic properties or lower the seizure threshold.

Patients on antidepressants or antipsychotics should consult a pharmacist for interaction screening and monitoring.

High‑risk combination checklist:

• Avoid alcohol while initiating therapy.
• Do not use with MAOIs or within 14 days of MAOI therapy.
• Review all CNS depressants and anticholinergic drugs with a pharmacist.
• Monitor for increased sedation, confusion, or urinary retention.

Providers should consult provincial drug interaction tools and the Health Canada database for updates on drug conflicts.

Latest Evidence & Insights

What does the clinical evidence say about cyproheptadine’s effects?

Antihistamine effects of cyproheptadine are well established, while evidence for appetite stimulation is largely clinical and observational with variable quality.

Evidence for migraine prevention is limited and supports only selective use as part of multimodal prophylaxis in selected patients.

One‑line takeaway: cyproheptadine is effective as an antihistamine; evidence for appetite stimulation and migraine prevention is weaker and largely clinician‑observational.

Note the paucity of recent high‑quality Canadian randomized controlled trials and advise shared decision‑making when prescribing off‑label.

Alternative Choices

What are reasonable alternatives if Periactin is unsuitable or unavailable?

Second‑generation antihistamines such as loratadine, cetirizine, and fexofenadine are less sedating and usually preferred for routine allergy care in Canada.

Other first‑generation options include chlorpheniramine and diphenhydramine, which are sedating and shorter acting.

For appetite stimulation the alternative depends on the cause and may include nutritional support or specialist options such as megestrol in oncology contexts.

Pros/cons checklist for common alternatives:

• Loratadine/Cetirizine/Fexofenadine: less sedation, often OTC, widely available; may be less effective for severe itch in some patients.
• Diphenhydramine/Chlorpheniramine: effective antihistamines but cause marked sedation and anticholinergic effects.
• Megestrol (specialist): possible appetite stimulant in cancer cachexia, requires specialist oversight.

Regulation Snapshot

How is Periactin / cyproheptadine regulated internationally and in Canada?

Periactin is marketed widely in countries such as Australia, India, and the UK and generics are available in the USA and elsewhere.

Registration varies by country; for example, Periactin is registered with the Australian TGA (AUST R 62384) and in India it is available OTC or by prescription depending on indication.

Legal classification differs: OTC in Australia and India for some uses, prescription only in USA and EU.

Patients in Canada should verify whether a Periactin or cyproheptadine product has an active Health Canada DIN or is being supplied via an import authorisation.

Coverage across provinces varies and inclusion under Ontario Drug Benefit, BC PharmaCare, or RAMQ depends on formulary listings and clinical criteria.

Regulatory checklist for patients and clinicians:

• Check for a valid DIN on the product.
• Ask the pharmacist about import status or special authorisations.
• Verify provincial formulary coverage before assuming reimbursement.

Helpful links: consult the Health Canada Drug Product Database and provincial drug plan pages for the most current information.

FAQ Section

Is Periactin available over the counter in Canada?

Availability varies; check Health Canada/DIN and ask your community pharmacy — many pharmacies can order it or suggest alternatives.

Can children take cyproheptadine?

Yes for children aged two years and older with typical dosing of 2 mg (½ tablet) two to three times daily; avoid use in infants and watch for paradoxical excitement in some children.

Will it make me gain weight?

Increased appetite and weight gain are common when cyproheptadine is used for appetite stimulation; monitor weight and metabolic health regularly.

How long before I know it works?

Allergy relief may be noticed within hours, while appetite effects often appear over 2–6 weeks.

What if I miss a dose?

Take the missed dose as soon as remembered unless it is close to the next dose; do not double up.

Printable one‑page FAQ for patients: include DIN check, pediatric dosing, weight monitoring advice, and emergency contact details.

Guidelines For Proper Use

What are practical pharmacist and patient recommendations for using Periactin safely?

Always confirm the product DIN, check for contraindications and drug interactions, start at the lowest effective dose, and warn patients about sedation risk.

Advise bilingual labelling or translated counselling for francophone patients in Quebec and bilingual communities.

For rural patients with limited pharmacy access arrange mail order or a pharmacist consultation by phone and ensure prescription validity across provinces.

Practical checklist for clinicians and patients:

• Confirm indication and document baseline weight and vital signs if using for appetite stimulation.
• Review other medications for MAOI use or sedative combinations.
• Start at lowest effective dose and schedule follow‑up at 2–6 weeks to assess response and side effects.
• Provide clear overdose instructions and emergency contact numbers.
• Store below 25°C and keep in original packaging.

One‑page counselling script for pharmacists: explain dosing, sedation warnings, interactions with MAOIs and alcohol, pediatric dosing limits, and when to seek urgent care.

Delivery Across Canada (English)